OverviewSuggest Edit

AngioDynamics is a provider of medical devices used by interventional radiologists, nephrologists, and surgeons for the treatment of peripheral vascular disease, vascular access, and for use in oncology and surgical settings. The company designs, manufactures, and sells a range of medical, surgical, and diagnostic devices that are generally used in minimally invasive, image-guided procedures. Its product line includes radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products, and venous products.

TypePublic
Founded1988
HQLatham, NY, US
Websiteangiodynamics.com
Employee Ratings3.7
Overall CultureD+

Latest Updates

Employees (est.) (May 2021)800
Job Openings25
Revenue (FY, 2021)$291 M(+11%)
Share Price (Oct 2021)$25.8
Cybersecurity ratingDMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at AngioDynamics

Jim Clemmer

Jim Clemmer

President, Chief Executive Officer
Michael Tarnoff

Michael Tarnoff

Director
Steve Trowbridge

Steve Trowbridge

Executive Vice President , Chief Financial Officer
Chad Campbell

Chad Campbell

Senior Vice President, General Manager of Vascular Access Global Business Unit
Dave Helsel

Dave Helsel

Senior Vice President, Global Operations and R&D
Benjamin Davis

Benjamin Davis

Senior Vice President, Corporate Development and Strategy
Show more

AngioDynamics Office Locations

AngioDynamics has offices in Latham, Glens Falls, Marlborough, Queensbury and in 3 other locations
Latham, NY, US (HQ)
14 Plaza Dr
Glens Falls, NY, US
8 Glens Falls Tech Park
Marlborough, MA, US
26 Forest St, Marlborough
Queensbury, NY, US
603 Queensbury Ave
Oakville, CA
2275 Upper Middle Rd E #101
Hong Kong, HK
Suite 6, 6/F Luk Kwok Centre, 72 Gloucester Rd, Wan Chai
Show all (7)

AngioDynamics Financials and Metrics

AngioDynamics Revenue

Embed Graph
View revenue for all periods
AngioDynamics's revenue was reported to be $291.01 m in FY, 2021
USD

Revenue (FY, 2021)

291.0m

Gross profit (FY, 2021)

156.8m

Gross profit margin (FY, 2021), %

53.9%

Net income (FY, 2021)

(31.5m)

EBIT (FY, 2021)

(35.3m)

Market capitalization (14-Oct-2021)

982.4m

Closing stock price (14-Oct-2021)

25.8

Cash (31-May-2021)

48.2m

EV

944.0m
AngioDynamics's current market capitalization is $982.4 m.
Annual
USDFY, 2018FY, 2019FY, 2020FY, 2021

Revenue

344.3m270.6m264.2m291.0m

Revenue growth, %

(2%)(21%)(2%)

Cost of goods sold

167.4m114.6m113.9m134.2m

Gross profit

176.9m156.0m150.3m156.8m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Revenue

85.3m91.5m86.3m66.0m70.0m69.8m70.2m72.8m71.2m

Cost of goods sold

40.9m42.4m39.7m27.8m28.5m29.5m34.5m32.6m32.7m

Gross profit

44.5m49.1m46.7m38.2m41.5m40.3m35.8m40.2m38.5m

Gross profit Margin, %

52%54%54%58%59%58%51%55%54%
Annual
USDFY, 2018FY, 2019FY, 2020FY, 2021

Cash

74.1m227.6m54.4m48.2m

Accounts Receivable

39.4m43.6m31.3m35.4m

Prepaid Expenses

4.3m4.0m7.3m8.7m

Inventories

48.9m40.1m59.9m48.6m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Cash

24.8m42.8m41.7m83.6m41.2m27.2m47.9m58.0m54.5m

Accounts Receivable

40.2m43.4m44.2m32.5m34.0m35.6m33.6m33.6m33.2m

Prepaid Expenses

4.9m4.8m4.4m4.9m6.5m11.4m8.0m8.5m9.0m

Inventories

49.7m50.6m52.4m45.2m50.2m54.9m52.8m49.6m49.0m
Annual
USDFY, 2018FY, 2019FY, 2020FY, 2021

Net Income

16.3m61.3m(166.8m)(31.5m)

Depreciation and Amortization

23.2m25.9m23.8m25.9m

Inventories

5.7m(1.4m)(18.8m)11.5m

Accounts Payable

(7.1m)5.2m(15.5m)4.9m
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021Q3, 2021

Net Income

(469.0k)1.7m2.5m(1.3m)(4.0m)(9.7m)(4.3m)(8.5m)(12.1m)

Depreciation and Amortization

5.6m12.3m19.2m5.2m11.1m17.6m6.6m13.0m19.4m

Inventories

(761.0k)(955.0k)(2.7m)(5.2m)(10.0m)(14.0m)7.2m10.5m11.1m

Accounts Payable

(13.4m)(10.1m)(10.3m)(17.6m)(8.8m)(18.0m)(10.1m)(3.8m)(1.7m)
USDFY, 2018

Revenue/Employee

300.7k

Debt/Equity

0.2 x

Debt/Assets

0.1 x

Financial Leverage

1.3 x
Show all financial metrics

AngioDynamics Operating Metrics

FY, 2017FY, 2018FY, 2019FY, 2020

Manufacturing Facilities

4422

Manufacturing Facilities, sq. ft.

385.5 k385.5 k318 k317.4 k

Sales Offices

1121

Selling Space, sq. ft.

10.1 k8.1 k12.1 k8.1 k
Show all operating metrics

AngioDynamics Acquisitions / Subsidiaries

Company NameDateDeal Size
Eximo Medical, Ltd.October 02, 2019$45.8 m
RadiaDyne LLCSeptember 21, 2018$75 m
Clinical DevicesAugust 31, 2013
Vortex MedicalOctober 31, 2012
Navilyst Medical, Inc.January 31, 2012
FlowMedicaJanuary 12, 2009
OncovionicMay 31, 2008
RITA Medical SystemsJanuary 29, 2007$220 m
AngioDynamics Canada Inc.
AngioDynamics France, SARL
Show more

AngioDynamics Revenue Breakdown

Embed Graph

AngioDynamics revenue breakdown by business segment: 21.6% from Oncology/Surgery, 35.7% from Vascular Access and 42.7% from Vascular Interventions and Therapies

AngioDynamics revenue breakdown by geographic segment: 78.7% from United States and 21.3% from International

AngioDynamics Cybersecurity Score

Cybersecurity ratingPremium dataset

D

69/100

SecurityScorecard logo

AngioDynamics Online and Social Media Presence

Embed Graph

AngioDynamics Company Culture

  • Overall Culture

    D+

    62/100

  • CEO Rating

    F

    27/100

  • Compensation

    F

    42/100

Learn more on Comparably

AngioDynamics News and Updates

$ 156.6 Million Growth in Global Endovenous Ablation Devices Market During 2021-2025 | Featuring Key Vendors Including AngioDynamics Inc., AtriCure Inc., and Eufoton srl | Technavio

NEW YORK, Feb. 22, 2021 /PRNewswire/ -- Tavio announces the release of its latest report on the endovenous ablation devices market. The market is segmented by product (EVLT devices, RFA devices, and NTNT devices) and geography (North America, Europe, Asia, and ROW). Get a Free Sample...

AngioDynamics to pay $12.5 mln over false claims allegations -U.S. Justice Dept

AngioDynamics Inc has agreed to pay the U.S. government $12.5 million to resolve allegations it caused healthcare providers to submit false claims to federal healthcare programs over the use of two medical devices, the Justice Department said on Wednesday.

Iv Equipment Market to Exceed US$ 12 Bn in 2022

IV Equipment Market to Have a Value of More than US$ 12 Billion by 2022; Europe and North America the Largest Regions Posted via Industry Today. Follow us on Twitter @IndustryToday

Angiographic Catheters Market Forecast Report Offers Actionable Insights

Angiographic Catheters Market Forecast Report Offers Actionable Insights Posted via Industry Today. Follow us on Twitter @IndustryToday

Endometrial Ablation Market to Witness Steady Expansion at 5.5% CAGR During 2016-2024

Transparency Market Research has announced the addition of the “Endometrial Ablation Market: Global Industry Analysis and Opportunity Assessment, 2016-2024"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more

AngioDynamics Blogs

AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance

Fiscal 2022 First Quarter Highlights Net sales of $77.0 million increased 9.6% compared to the prior-year quarter Gross margin of 52.1% increased... The post AngioDynamics Reports Fiscal 2022 First Quarter Financial Results; Updates Guidance appeared first on AngioDynamics.

AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021

LATHAM, N.Y.–(BUSINESS WIRE)–Sep. 15, 2021– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular... The post AngioDynamics to Report Fiscal 2022 First Quarter Financial Results on September 30, 2021 appeared first on AngioDynamics.

New AMA Category III CPT Code Issued for Transcatheter Removal/Debulking of Intracardiac Masses

Latham, New York, August 24, 2021 – AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices... The post New AMA Category III CPT Code Issued for Transcatheter Removal/Debulking of Intracardiac Masses appeared first on AngioDynamics.

AngioDynamics Receives FDA Approval for PRESERVE Study

Study Will Assess Use of NanoKnife System in Prostate Tissue Ablation Latham, New York, August 11, 2021 – AngioDynamics, Inc.... The post AngioDynamics Receives FDA Approval for PRESERVE Study appeared first on AngioDynamics.

AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference

LATHAM, N.Y.–(BUSINESS WIRE)–Jul. 29, 2021– AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular... The post AngioDynamics to Present at the Canaccord Genuity Virtual Growth Conference appeared first on AngioDynamics.

AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results

Fiscal 2021 Fourth Quarter Highlights Net sales of $76.8 million increased 31.7% compared to the prior-year quarter Gross margin of 55.1% increased... The post AngioDynamics Reports Fiscal 2021 Fourth Quarter and Full-Year Financial Results appeared first on AngioDynamics.
Show more

AngioDynamics Frequently Asked Questions

  • When was AngioDynamics founded?

    AngioDynamics was founded in 1988.

  • Who are AngioDynamics key executives?

    AngioDynamics's key executives are Jim Clemmer, Michael Tarnoff and Steve Trowbridge.

  • How many employees does AngioDynamics have?

    AngioDynamics has 800 employees.

  • What is AngioDynamics revenue?

    Latest AngioDynamics annual revenue is $291 m.

  • What is AngioDynamics revenue per employee?

    Latest AngioDynamics revenue per employee is $363.8 k.

  • Who are AngioDynamics competitors?

    Competitors of AngioDynamics include Bioventus, Argon Medical Devices and Inari Medical.

  • Where is AngioDynamics headquarters?

    AngioDynamics headquarters is located at 14 Plaza Dr, Latham.

  • Where are AngioDynamics offices?

    AngioDynamics has offices in Latham, Glens Falls, Marlborough, Queensbury and in 3 other locations.

  • How many offices does AngioDynamics have?

    AngioDynamics has 7 offices.